AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
AngioDynamics (ANGO) Tops Q4 EPS by 3c; Affirms FY18 Outlook
July 18, 2017 6:01 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $86.9 million versus the consensus estimate of $90.74 million.
The quarter, and year, reflect a commitment to strengthening our business, improving our core operational efficiency... More
